POLISCOPE
Back to feed
SB 844FLORIDA · STATEWIDESession 2026signed
Enacted

New Continuing Education Requirements for Doctors Prescribing Controlled Substances

Original title: Sickle Cell Disease Care Management and Treatment Continuing Education

March 30, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Current status: signed.

Last action
Chapter No. 2026-6Mar 30, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This change directly impacts the process for all Florida-based practitioners registered with the DEA to prescribe , requiring them to update their curriculum to include specific pain management protocols for sickle cell patients.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Health care practitioners

Must complete updated continuing education including sickle cell pain management to maintain their license to prescribe controlled substances.

Sickle cell disease patients

The law mandates that their specific pain management needs be included in the training curriculum for their healthcare providers.

What changed

Current stage: signed.

What's next

Next step not available in the current record.

Summary

This law requires doctors and other health care practitioners who prescribe to include training on sickle cell disease pain management in their mandatory biennial continuing education courses. Practitioners who fail to complete this updated training will be unable to renew their professional licenses.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who is required to take this new training?
Any person registered with the U.S. Drug Enforcement Administration (DEA) who is authorized to prescribe and is subject to in Florida.
Does this add extra hours to my continuing education requirements?
No, the course must be included within the total number of continuing education hours already required by law.
What happens if I don't complete the course?
The department will not renew your professional license.

Why It Matters

This change directly impacts the process for all Florida-based practitioners registered with the DEA to prescribe , requiring them to update their curriculum to include specific pain management protocols for sickle cell patients.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Voting Record

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Integration of Specialized Pain Management into General Training

The legislature is moving to integrate specific disease-state pain management (sickle cell) into the broader, mandatory opioid prescribing curriculum for all practitioners.

Connected Entities

Sources

Open source document

openstates.org

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record